Abstract
Unintentional bupropion pediatric exposures uncommonly report severe clinical effects such as seizures. We sought to determine the clinical effects and case outcomes for unintentional bupropion ingestions in children age ≤6 years. The National Poison Data System was queried for unintentional, acute, single substance bupropion ingestions in children age ≤6 years for the time period January 1, 2000 to February 27, 2007 for cases followed to a known outcome. If exposure amount was reported, a mg/kg dose was determined; when weight was absent, it was interpolated from the available data set. An adverse neurological effect (ANE) was defined as seizure (single, multi/discrete, and status) or coma. For analysis, the outcomes of no effect and mild outcome were grouped, and the outcomes of moderate outcome, major outcome, and death were grouped. A subset of case notes were reviewed for accuracy. Seven thousand one hundred eighteen cases met the inclusion criteria, with 1,154 cases excluded because of multiple substances and coding errors, resulting in 5,964 cases. A total of 4,557 cases (76.4%) were managed at or sent to a HCF. The most common clinical effects reported were nausea/vomiting (4.3%), tachycardia (3.9%), agitated/irritable (3.1%), drowsiness/lethargy (2.4%), and seizure (1.4%). There were no deaths. Overall, there was a 3.3% rate of moderate/major outcomes. A mg/kg dose was calculable in 76.1% of cases; the average amount for the no effect/minor cases and moderate/major effect was 13.8 ± 18.8 and 38.8 ± 44.0 mg/kg, respectively (p < 0.0001). Average time until development of seizures was 4.2 ± 3.2 h with a maximum of 14 h. Few children develop toxicity from unintentional reported bupropion ingestions, with about 1.5% of patients developing an ANE.
Keywords: Bupropion, Pediatrics, NPDS, Poison centers, Unintentional
Full Text
The Full Text of this article is available as a PDF (104.4 KB).
Footnotes
Source of Funding
None.
Previous presentation as an abstract: Beuhler MC, Spiller HA. The outcome of unintentional pediatric bupropion ingestions: a TESS database review. Clin Tox 45(6):630, 2007
References
- 1.Micromedex® healthcare series, Thomson Reuters, Greenwood village, Colorado. Accessed February 2007
- 2.Instructions for the American Association of Poison Control Centers Toxic Exposure Surveillance System, Copyright AAPCC, Printed 2001
- 3.CDC (2009) http://www.cdc.gov/growthcharts. Published May 30, 2000, modified April 20, 2001
- 4.Stahl SM, Pradko M, Haight B, Modell JG, Rockett CB, Learned-Coughlin S. Review of the neuropharmacology of bupropion. J Clin Psych. 2004;6(4):159–166. doi: 10.4088/pcc.v06n0403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Balit C, Lynch CN, Isbister GK. Bupropion poisoning: a case series. MJA. 2003;178(2):61–63. doi: 10.5694/j.1326-5377.2003.tb05064.x. [DOI] [PubMed] [Google Scholar]
- 6.Belson MG, Kelly TR. Bupropion exposures: clinical manifestations and medical outcome. J Emerg Med. 2002;23(3):223-–230. doi: 10.1016/S0736-4679(02)00522-X. [DOI] [PubMed] [Google Scholar]
- 7.Shepherd G, Velez LI, Keyes DC. Intentional bupropion overdoses. J Emerg Med. 2004;27(2):147–151. doi: 10.1016/j.jemermed.2004.02.017. [DOI] [PubMed] [Google Scholar]
- 8.Spiller HA, Bosse GM, Beuhler M, Gray T, Baker SD (2010) Unintentional ingestion of bupropion in children. J Emerg Med (in press) [DOI] [PubMed]
- 9.Welbutrin XL (2007) Package insert. GlaxoSmithKline, Research Triangle Park